IMPACT OF THE TIME OF INITIATION AND LINE OF BIOLOGIC THERAPY ON THE RETENTION RATE OF SECUKINUMAB (SECU) IN AXIAL SPONDYLOARTHRITIS (AXSPA). DATA FROM THE FRENCH MULTICENTER RETROSPECTIVE FORSYA STUDY

被引：0
|
作者：
Dougados, M. [1 ]
Lardy-Cleaud, A. [2 ]
Desfleurs, E. [3 ]
Claudepierre, P. [4 ]
Goupille, P. [5 ]
Ruyssen-Witrand, A. [6 ]
Saraux, A. [7 ]
Tournadre, A. [8 ]
Wendling, D. [9 ]
Lukas, C. [10 ,11 ]
机构：
[1] Hop Cochin, Assistance Publ Hop Paris, Dept Rheumatol, Paris, France
[2] RCTs Clin Res Org, Biostat, Lyon, France
[3] Novartis, Med Affairs, Rueil Malmaison, France
[4] Hop Henri Mondor, Assistance Publ Hop Paris, Dept Rheumatol, Creteil, France
[5] Univ Hosp Tours, Dept Rheumatol, Tours, France
[6] Univ Hosp Toulouse, Rheumatol Ctr, Toulouse, France
[7] Univ Hosp Brest, Dept Rheumatol, Brest, France
[8] Univ Hosp Clermont Ferrand, Dept Rheumatol, Clermont Ferrand, France
[9] Univ Hosp Besancon, Dept Rheumatol, Besancon, France
[10] Univ Hosp Montpellier, Dept Rheumatol, Montpellier, France
[11] Univ Hosp Montpellier, Dept Rheumatol, Montpellier, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Prognostic factors; Spondyloarthritis; Real-world evidence;
D O I：
10.1136/annrheumdis-2023-eular.2356
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1123
引用
收藏
页码：888 / 889
页数：2
相关论文
共 5 条
  • [1] Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
    Dougados, Maxime
    Lardy-Cleaud, Audrey
    Desfleurs, Emilie
    Claudepierre, Pascal
    Goupille, Philippe
    Ryussen-Witrand, Adeline
    Saraux, Alain
    Tournadre, Anne
    Wendling, Daniel
    Lukas, Cedric
    RMD OPEN, 2024, 10 (01):
  • [2] IMPACT OF BASELINE CRP LEVEL ON SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA
    Goupille, P.
    Dougados, M.
    Lardy-Cleaud, A.
    Desfleurs, E.
    Claudepierre, P.
    Ruyssen-Witrand, A.
    Saraux, A.
    Tournadre, A.
    Lukas, C.
    Wendling, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 886 - 887
  • [3] FACTORS ASSOCIATED WITH SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA
    Dougados, M.
    Lucas, J.
    Desfleurs, E.
    Claudepierre, P.
    Goupille, P.
    Ruyssen-Witrand, A.
    Saraux, A.
    Tournadre, A.
    Wendling, D.
    Lukas, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 398 - 398
  • [4] Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
    Dougados, Maxime
    Lucas, Julien
    Desfleurs, Emilie
    Claudepierre, Pascal
    Goupille, Philippe
    Ruyssen-Witrand, Adeline
    Saraux, Alain
    Tournadre, Anne
    Wendling, Daniel
    Lukas, Cedric
    RMD OPEN, 2023, 9 (01):
  • [5] DRUG RETENTION RATE OF THE FIRST TNF INHIBITOR IN RADIOGRAPHIC AND NON RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: DATA FROM A MULTICENTER STUDY
    Lopalco, G.
    Venerito, V.
    Cantarini, L.
    Emmi, G.
    Salaffi, F.
    Tafuri, S.
    Bianchi, F. P.
    Di Carlo, M.
    Gentileschi, S.
    Di Scala, G.
    Nivuori, M.
    Perniola, S.
    Fornaro, M.
    Anelli, M. G.
    Cacciapaglia, F.
    Scioscia, C.
    Fabiani, C.
    Galeazzi, M.
    Lapadula, G.
    Iannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1546 - 1546
1